![Elizabeth Anne Rollinson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Elizabeth Anne Rollinson
Keine laufenden Positionen mehr
Karriereverlauf von Elizabeth Anne Rollinson
Ehemalige bekannte Positionen von Elizabeth Anne Rollinson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Xenova Group Plc
![]() Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Corporate Officer/Principal | - | - |
Phogenix Imaging LLC | Corporate Officer/Principal | - | - |
Antikor Biopharma Ltd.
![]() Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | Direktor/Vorstandsmitglied | 01.04.2006 | - |
Ausbildung von Elizabeth Anne Rollinson
Imperial College London | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 4 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Doctorate Degree | 1 |
Sektoral
Commercial Services | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Xenova Group Plc
![]() Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Commercial Services |
Phogenix Imaging LLC | |
Antikor Biopharma Ltd.
![]() Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | Health Technology |